Square Pharmaceuticals PLC. reported earnings results for the second quarter and six months ended December 31, 2023. For the second quarter, the company reported sales was BDT 21,440.32 million compared to BDT 18,715.14 million a year ago. Revenue was BDT 18,518.95 million compared to BDT 16,187.08 million a year ago. Net income was BDT 5,244.98 million compared to BDT 5,126.18 million a year ago. Basic earnings per share from continuing operations was BDT 5.92 compared to BDT 5.78 a year ago.
For the six months, sales was BDT 43,053.77 million compared to BDT 37,528.42 million a year ago. Revenue was BDT 36,978.15 million compared to BDT 32,256.71 million a year ago. Net income was BDT 11,245.36 million compared to BDT 10,626.49 million a year ago. Basic earnings per share from continuing operations was BDT 12.69 compared to BDT 11.99 a year ago.